Off-Label Recombinant Factor VIIa Use and Thrombosis in Children: A Multi-Center Cohort Study
- 31 May 2011
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 158 (5), 820-825.e1
- https://doi.org/10.1016/j.jpeds.2010.10.038
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Intravenous Immunoglobulin in Children with Streptococcal Toxic Shock SyndromeClinical Infectious Diseases, 2009
- Defining the role of recombinant activated factor VII in pediatric cardiac surgery: Where should we go from here?*Pediatric Critical Care Medicine, 2009
- Off‐label use of rFVIIa in children with excessive bleeding: A consecutive study of 153 off‐label uses in 139 childrenPediatric Blood & Cancer, 2009
- Pediatric Off-label Use of Recombinant Factor VIIaPEDIATRICS, 2009
- The Effect of Activated Factor VII for Intracerebral Hemorrhage Beyond 3 Hours Versus Within 3 HoursStroke, 2008
- Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophiliaPublished by Wiley ,2007
- Recombinant factor VIIa in paediatric bleeding disorders ? a 2006 reviewHaemophilia, 2006
- A multicenter assessment of recombinant factor VIIa off‐label usage: clinical experiences and associated outcomesTransfusion, 2005
- Safety and Feasibility of Recombinant Factor VIIa for Acute Intracerebral HemorrhageStroke, 2005
- The use of recombinant factor VIIa in the treatment of bleeding disordersBlood, 2004